Bloomberg News & Hagens Berman
4 shared events · Importance 3 · Last updated Jun 03, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
NewsDesk Dashboard
Regulatory
Bloomberg News: Bloomberg News reported on the FDA's warning letter to ImmunityBio, which brought the misleading claims to wider public and investor attention.
Hagens Berman: Hagens Berman is investigating claims that ImmunityBio violated federal securities laws and is urging investors with significant losses to join their class action lawsuit.
Apr 02, 2026 · 132 articles
NEWSDESK
Explore this relationship live
Track how Bloomberg News and Hagens Berman interact across events, view sentiment trends, and discover connected entities.
Open Dashboard